Chief Operating Officer, Nucleic Acid Production · MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Brian Neel

A named executive officer of MARAVAI LIFESCIENCES in every fiscal year CompBrief holds from FY2019 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,580,805

Salary $432,154Stock awards $447,440

FY2021: $797,382

6th of 6 named executive officers at Maravai Lifesciences by FY2022 total.

6 named officers on file for MARAVAI LIFESCIENCES, FY2022

Brian Neel’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • MRVI’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MARAVAI LIFESCIENCES’s whole pay program stands against its peers

  • MARAVAI LIFESCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MRVI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 20, 2023 (DEF 14A).

Free

Get Brian Neel’s full pay file as a PDF — free

More than this page: up to 10 years of Brian’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Brian Neel compensation by year

MARAVAI LIFESCIENCES Summary Compensation Table · all 4 fiscal years held
In US dollars, as MARAVAI LIFESCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022
Salary$314,673$328,609$388,661$432,154
Bonus$0$0—$0
Stock awards$0$0$0$447,440
Option awards$428,000$874,160—$391,545
Non-equity incentive$142,436$649,943$400,000$309,666
Pension and deferred compensation$0$0$0—
All other$8,400$8,550$8,721—
Total$893,509$1,861,262$797,382$1,580,805

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MARAVAI LIFESCIENCES HOLDINGS, INC. DEF 14A filed April 20, 2023, accession 0001193125-23-108444, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MARAVAI LIFESCIENCES HOLDINGS, INC. filed document, accession 0001193125-23-108444. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2023.

$894K
$1.9M
$797K
$1.6M
FY19
FY20
FY21
FY22
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU17,000$243,270—
Option24,937—$26.32
Option28,750—$27.00
Option8,000—$0.00

Per the Outstanding Equity Awards at Fiscal Year-End table in MARAVAI LIFESCIENCES HOLDINGS, INC.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

MARAVAI LIFESCIENCES’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
William MartinFormer Chief Executive Officer$14,523,493
Carl HullChief Executive Officer and Executive Chairman of the Board$5,480,801
Peter LeddyChief Administrative Officer$3,923,498
Kevin HerdeChief Financial Officer$1,741,482
Christine DolanChief Operating Officer, Biologics Safety Testing$1,594,953
Brian Neel · this pageChief Operating Officer, Nucleic Acid Production$1,580,805

The full MARAVAI LIFESCIENCES compensation record

free company brief

This page is one person within MARAVAI LIFESCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the MARAVAI LIFESCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MARAVAI LIFESCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Brian Neel's compensation dossier · One-time report. No refunds.